Nermeen Varawalla Email and Phone Number
Nermeen Varawalla work email
- Valid
- Valid
- Valid
- Valid
- Valid
Nermeen Varawalla personal email
Chief Medical Officer, ScancellChair and Non-Executive Director, CRISM TherapeuticsPresident UK INSEAD Alumni AssociationPresident Somerville Association
Scancell Ltd
View-
Chief Medical OfficerScancell Ltd Aug 2024 - PresentOxford, GbMember of Leadership Team focused on the late stage clinical development of immunotherapies for advanced cancer. -
Chair And Non Executive DirectorCrism Therapeutics May 2024 - PresentAn AIM listed bio-pharmaceutical company developing Chemoseed, a proprietary drug delivery technology for localised chemotherapy with high grade glioma, brain tumour being the lead indication. -
PresidentInsead Alumni Association Uk Sep 2021 - PresentLondon, GbRepresent over 6,000 UK-based alumni, chair the management committee of this registered charity to deliver membership benefits & alumni engagement through a vibrant events programme, interface with the Board, Dean and Faculty of INSEAD and build partnerships with corporate sponsors and donors -
Chair, Medical Advisory GroupAtorvia Health Technologies Aug 2020 - PresentKanata, Ontario, CaAn early-stage biopharmaceutical company seeking to develop new medicines for cardio-renal disease -
PresidentSomerville Association Mar 2022 - PresentChair a committee of volunteers who represent the worldwide alumni of Somerville College, University of Oxford, represent alumni at college and university matters and build alumni engagement via events and special interest networks
-
Chief Medical OfficerRelief Therapeutics Holding Ag Jan 2022 - Jun 2023Geneve, ChRelief Therapeutics is a listed biopharmaceutical company with portfolio of assets for the treatment of pulmonary, rare metabolic and genetic dermatological diseases. As a member of the Senior Leadership Team was responsible for the global medical affairs and clinical development functions. -
Chief Medical Officer & Head Clinical DevelopmentAtlantic Healthcare Plc Sep 2020 - Dec 2021A specialist pharmaceutical company, developing therapeutics that address unmet needs and rare diseases, with a focus on the gastro-instestinal tractLate stage clinical development portfolio investigating bowel disorders in multiple patient populations
-
Senior Vice President, Head Of Clinical DevelopmentBtg International May 2016 - Dec 2018BTG, a FTSE listed medical device & speciality pharmaceutical business, acquired by Boston Scientific Corporation• Led a global team (n=60) with responsibility for FDA & global market access targeted, clinical development of the speciality pharmaceutical and interventional medicine product portfolios• Delivered transformational change to BTG’s Clinical Development organisation through improvements in people, process and culture with significant impact on project delivery• Led the corporate initiative to pilot innovative approaches for the collection, curation and analysis of multi-source clinical data using Big Data & Machine Learning technologies• Reporting to the Chief Scientific Officer was a Member of the R&D Leadership team providing the clinical viewpoint on corporate matters, in particular M&A advice and execution
-
Executive Vp, Lambda Therapeutic Research & Head Development, Accord Healthcare, Intas GroupLambda Therapeutic Research & Accord Healthcare, Intas Group Aug 2013 - Apr 2016Intas is a privately held, specialty pharmaceutical company headquartered in India with over 50% of its USD 1 billion revenues accrued in international markets. My key responsibilities were:1. Clinical development and regulatory strategy for Accord Healthcare Europe 2. FDA & EMA product development for Intas’ portfolio (n=26) of biosimilars, innovative formulations, dermatology applications and nanosomal lipid delivery systems3. The group’s full service contract research organisation (CRO), Lambda Therapeutic Research, with 400 employees in India, Poland, Canada & UK.
-
Ceo & FounderEccro Apr 2010 - Jul 2013• Established and grew a differentiated, India specialist, late phase clinical CRO backed by private equity investment• Partnered with IDIS Pharma, to set up India’s first “named patient” medicines business
-
Sector Specialist For India Life Sciences & HealthcareUk Trade & Investment Aug 2009 - Mar 2010London, GbProvided strategic and operational advice to UK businesses seeking entry or growth in the Indian Healthcare & Life Sciences marketHelped attract inward investment to the UK from Indian Healthcare & Life Sciences businesses -
Vice PresidentPra Health Sciences 2004 - 2008Raleigh, North Carolina, UsA leading global CRO with 10,000 employees in 70 offices. I held three roles in sequence: Head European Sales & Marketing, Corporate Development & Scientific & Medical Affairs. • Led PRA’s European sales team to achieve record annual sales • Scientific, clinical & operational expertise for over 50 clinical trials in many disease areas• Led acquisition and integration of Sterling Synergy to establish data management & clinical trials business in India • Participated in the growth of the emerging county clinical trial businesses (China, Latin America & Eastern Europe) -
Founder & CeoPerinclinical 2002 - 2004Incubated PerinClinical, one of the early India focused clinical CROs, developed operational capabilities & clinical trial site relationships before being acquired by PRA International.
-
Manager, Healthcare & Life Sciences Strategy Consulting PracticeAccenture Jan 2001 - Aug 2002Dublin 2, IeConsulting projects for biopharmaceutical companies included: a drug development redesign programme, organizational re-structuring for a European R&D group and developing a business strategy for markets with changed Intellectual Property regulations. -
Specialist In Obstetrics & GynaecologyNhs 1993 - 1998GbMRCOG, Membership of the Royal College of Obstetrics & Gynaecology, UK
Nermeen Varawalla Skills
Nermeen Varawalla Education Details
-
InseadBusiness -
University Of OxfordClinical Medicine -
University Of MumbaiObstetrics And Gynecology
Frequently Asked Questions about Nermeen Varawalla
What company does Nermeen Varawalla work for?
Nermeen Varawalla works for Scancell Ltd
What is Nermeen Varawalla's role at the current company?
Nermeen Varawalla's current role is Business Leader in the Pharmaceutical Industry with clinical development expertise.
What is Nermeen Varawalla's email address?
Nermeen Varawalla's email address is ne****@****cro.com
What schools did Nermeen Varawalla attend?
Nermeen Varawalla attended Insead, University Of Oxford, University Of Mumbai.
What are some of Nermeen Varawalla's interests?
Nermeen Varawalla has interest in Pharmaceuticals In Emerging Markets, Drug Development.
What skills is Nermeen Varawalla known for?
Nermeen Varawalla has skills like Clinical Trials, Clinical Research, Cro, Pharmaceutical Industry, Drug Development, Strategy, Lifesciences, Healthcare, Regulatory Submissions, Medicine, Molecular Biology, Oncology.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial